These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 35711027)
1. D3 Receptors and PET Imaging. Koohsari S; Yang Y; Matuskey D Curr Top Behav Neurosci; 2023; 60():251-275. PubMed ID: 35711027 [TBL] [Abstract][Full Text] [Related]
2. Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO. Girgis RR; Slifstein M; D'Souza D; Lee Y; Periclou A; Ghahramani P; Laszlovszky I; Durgam S; Adham N; Nabulsi N; Huang Y; Carson RE; Kiss B; Kapás M; Abi-Dargham A; Rakhit A Psychopharmacology (Berl); 2016 Oct; 233(19-20):3503-12. PubMed ID: 27525990 [TBL] [Abstract][Full Text] [Related]
3. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350 [TBL] [Abstract][Full Text] [Related]
4. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO. Caravaggio F; Nakajima S; Borlido C; Remington G; Gerretsen P; Wilson A; Houle S; Menon M; Mamo D; Graff-Guerrero A Neuropsychopharmacology; 2014 Nov; 39(12):2769-76. PubMed ID: 24874713 [TBL] [Abstract][Full Text] [Related]
6. Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo. Gallezot JD; Beaver JD; Gunn RN; Nabulsi N; Weinzimmer D; Singhal T; Slifstein M; Fowles K; Ding YS; Huang Y; Laruelle M; Carson RE; Rabiner EA Synapse; 2012 Jun; 66(6):489-500. PubMed ID: 22213512 [TBL] [Abstract][Full Text] [Related]
7. Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies. Mach RH; Luedtke RR J Labelled Comp Radiopharm; 2018 Mar; 61(3):291-298. PubMed ID: 28857231 [TBL] [Abstract][Full Text] [Related]
8. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157 [TBL] [Abstract][Full Text] [Related]
9. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711 [TBL] [Abstract][Full Text] [Related]
10. Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry. Caravaggio F; Scifo E; Sibille EL; Hernandez-Da Mota SE; Gerretsen P; Remington G; Graff-Guerrero A Exp Eye Res; 2018 Oct; 175():32-41. PubMed ID: 29883636 [TBL] [Abstract][Full Text] [Related]
11. Selectivity of probes for PET imaging of dopamine D3 receptors. Doot RK; Dubroff JG; Labban KJ; Mach RH Neurosci Lett; 2019 Jan; 691():18-25. PubMed ID: 29518538 [TBL] [Abstract][Full Text] [Related]
12. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum. Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726 [TBL] [Abstract][Full Text] [Related]
13. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [ Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO. Tateno A; Sakayori T; Kim WC; Honjo K; Nakayama H; Arakawa R; Okubo Y Int J Neuropsychopharmacol; 2018 Jun; 21(6):522-527. PubMed ID: 29346639 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task. Suridjan I; Rusjan P; Addington J; Wilson AA; Houle S; Mizrahi R J Psychiatry Neurosci; 2013 Mar; 38(2):98-106. PubMed ID: 23010256 [TBL] [Abstract][Full Text] [Related]
17. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice. Rabiner EA; Slifstein M; Nobrega J; Plisson C; Huiban M; Raymond R; Diwan M; Wilson AA; McCormick P; Gentile G; Gunn RN; Laruelle MA Synapse; 2009 Sep; 63(9):782-93. PubMed ID: 19489048 [TBL] [Abstract][Full Text] [Related]